Quiz Quiz: Cetuximab vs Cisplatin for Locoregional Control of HNSCC February 02, 2021 <section><h2>True or False: In combination with radiotherapy, cisplatin is inferior to cetuximab for the locoregional control of advanced head and neck squamous cell cancer.</h2></section><section><h2><h2>True or False: In combination with radiotherapy, cisplatin is inferior to cetuximab for the locoregional control of advanced head and neck squamous cell cancer.</h2></h2></section><section><h2></h2></section><section><h3></h3></section>
